krn 5500
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started May 1, 1997 (NCT00002923)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- krn5500
- krn5500
- krn5500
- krn 5500
- krn-5500
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00474916 | Phase 2 | Jun 1, 2006 | DARA Therapeutics, Harvard University |
| NCT00017238 | Phase 1 | Feb 1, 2002 | Harvard University, National Cancer Institute (NCI) |
| NCT00002923 | Phase 1 | May 1, 1997 | National Cancer Institute (NCI), Wayne State University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 2 | 0 | 2 | 2002 |
| National Cancer Institute (NCI) | Government | 2 | 1 | 1 | 1997 |
| DARA Therapeutics | For profit | 1 | 1 | 1 | 2006 |
| Wayne State University | Academic/Hospital | 1 | 1 | 1 | 1997 |
4 organizations
Page 1 / 1